GLP-1 AGONISTS, COMPOSITIONS, METHODS AND USES

摘要

The present invention relates to at least one novel human GLP-l mimetibody or agonist, or specified portion or variant, including isolated nucleic acids that encode at least one GLP-1 mimetibody or agonist, or specified portion or variants, GLP-l mimetibody or agonist, or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including diabetes related therapeutic and/or diagnostic compositions, methods and devices. FIGURE 22B